[Pharm-policy] Utility Patent on a Generic Drug

[James Love]

Interesting query on tech-l regarding a cancer drug. Jamie


-------------------------
Subject:  [techno-l] Re: Utility Patent on a Generic Drug
   Date:  Wed, 18 Oct 2000 13:25:49 -0400
  From:  "Serge-Alain Wandji" <swandji@psu.edu>
    To:  <technobz@cyberwar.com>, <techno-l@lists.uventures.com>

Dear all,

One of our investigators has dicovered that a substance, which is
produced both by the body and synthetically, is effective is inhibiting
several cancers.  He has been granted a patent that covers the receptor
pathways inhibiting those cancers.  His data show that in some types of
cancers, the receptor is defective.  We are tying to license this
technology but face several issues.  For example, the drug in question
has been prescribed for many years for other uses and one concern is
that it would be difficult to track down what physicians will be
prescribing the drug for (cancer or other uses).  Has anybody faced this
type of scenario before and if so, what approach(es) might be
recommended for marketing and licensing.  Many thanks.  

Serge-Alain Wandji
Office of Technology Development
Milton S. Hershey Medical Center



---------------------------------------------------------------------
Uventures.com the home of Techno-L
Techno-L Archives are available on UVentures.com.  
To access the searchable archives, register FREE at
http://www.uventures.com

To subscribe, e-mail: techno-l-subscribe@lists.uventures.com
To unsubscribe, e-mail:techno-l-unsubscribe@lists.uventures.com
For additional commands, e-mail: techno-l-help@lists.uventures.com

-- 
James Love  mailto:love@cptech.org http://www.cptech.org
Consumer Project on Technology, P.O. Box 19367, Washington, DC 20036
voice 1.202.387.8030  fax  1.202.234.5176